Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Bicillin L-A for non-CNS syphilis
ACTRN12622000349741Phase 2Terminated
- Sponsor
- South Metropolitan Health Service
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of benzylpenicillin in syphilis, sponsored by South Metropolitan Health Service. Primary endpoint: Safety and tolerability composite. Started Oct 2022; status: terminated.
02
Drugs
benzylpenicillin
03
Conditions
syphilis
Beyond the preview
Go deeper on ACTRN12622000349741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000349741.